A deal that once looked like a Hollywood formality is now stuck in a four-country regulatory pileup. Paramount Skydance’s roughly $110 billion agreement to acquire Warner Bros. Discovery, signed February 27, 2026, is facing its most serious threat yet after British Culture Secretary Lisa Nandy said she is “minded to intervene” to block or reshape the transaction, citing risks to media plurality in the United Kingdom.

What Nandy Is Actually Objecting To

Nandy’s concern centers on how much of British television, streaming, and news a single owner would control if the merger closes as written. A combined Paramount-Warner would own Channel 5, TNT Sports, Cartoon Network, Nickelodeon, and CNN International in the UK, alongside the streaming services Paramount+ and HBO Max. Nandy has flagged a specific gap in existing law: the UK’s media plurality rules, she noted, currently do not cover the effect of a merger on streaming or video-on-demand services. Her department has said it will pursue secondary legislation to close that gap, a process that could extend the review well beyond the deal’s original timeline. A Paramount Skydance spokesperson pushed back, telling reporters the company remains confident the transaction poses “no media plurality issues in the UK” and said it is still committed to its stated closing timeline.

How the Deal Got Here

Paramount Skydance’s $31-a-share, all-cash bid beat out a rival offer from Netflix, which dropped out of the bidding war earlier in 2026. Warner Bros. Discovery shareholders approved the acquisition in April. Since then, the deal has run into a gauntlet of regulators applying very different standards. The U.S. Department of Justice closed its antitrust investigation on June 12, finding no competitive harm across streaming, linear television, or theatrical distribution. Weeks later, on July 20, a California federal court issued a temporary restraining order, pointing to Paramount’s projected 27% share of wide-release theatrical distribution as a potential antitrust problem. Two days after that, on July 22, the European Commission granted conditional approval, but only if Paramount exits United International Pictures, its European distribution joint venture with Universal. The UK’s review, triggered around June 30, is the fourth and most unresolved front.

Actors Join the Fight

The regulatory drama has drawn an unlikely group of public objectors: working actors. Benedict Cumberbatch, Alan Cumming, and Benedict Wong published an op-ed in The Guardian this week under the headline “A TV and cinema calamity could be disastrous for what you watch and what you know. Act now to stop that.” The trio argues the merger threatens British film and TV jobs, independent production financing, and editorial independence in news. Their sharpest point concerns journalism: Paramount already owns Channel 5 in Britain and CBS in the United States, and absorbing Warner Bros. Discovery would bring CNN and CNN International under the same roof. “If one commercially interested owner controls access to both [the CNN and CBS news archives], they control the raw material of our historical memory,” the actors wrote, framing the deal as a threat to editorial independence rather than simply a business transaction.

The Money Behind the Delay

Every extra month is getting expensive. Under the terms Paramount Skydance agreed to, additional consideration begins accruing on September 30 at a rate of 25 cents per share every 90 days, which works out to roughly $650 million per quarter, or about $7 million a day, owed on top of the original price if the deal doesn’t close on schedule. Paramount and Warner have agreed not to close the transaction until five days after a ruling on the antitrust merits, or June 1, 2027, whichever comes first, meaning a delay stretching into next year could tack on close to $1.7 billion in extra cost. There’s also a $7 billion termination fee that applies if regulators ultimately kill the deal outright, an amount personally guaranteed jointly and severally by Larry Ellison’s revocable trust, underscoring how much financial exposure sits behind the Ellison family’s push to control both Paramount and Warner Bros. Discovery.

The Counter-Argument

Paramount Skydance’s position is that combining with Warner Bros. Discovery is a defensive necessity, not a monopoly play. Executives have argued that streaming competition from Netflix, Amazon, and Disney, plus the decline of linear cable revenue, makes scale essential for a legacy media company to survive, and that global audiences benefit from a stronger, better-capitalized rival to those platforms. The company’s public statements have consistently framed the UK plurality concerns as unfounded, distinguishing between owning a broadcaster like Channel 5 and controlling the broader news ecosystem the actors’ op-ed describes. Regulators disagree sharply among themselves too: the DOJ’s clean bill of health stands in direct tension with the California court’s theatrical-market concerns and the EU’s insistence that Paramount unwind its Universal joint venture, showing there is no global consensus on whether this deal is actually anticompetitive.

What Happens Next

The near-term calendar is dense. The California antitrust case over theatrical distribution remains unresolved after the July 20 restraining order, and a ruling on the merits will determine how much longer the standstill agreement holds. Nandy’s department must still formally notify Paramount Skydance and Warner Bros. Discovery’s current owners before any UK intervention becomes official, a step that itself keeps the clock running toward the September 30 price-escalation deadline. If the various reviews drag past June 1, 2027, the companies’ own contractual outs come into play. For now, Paramount is holding to its “early fall 2026” closing target in public, but with four regulators applying four different tests, and a growing chorus of actors and lawmakers raising alarms about news ownership, the path to actually closing this deal looks far more contested than it did when shareholders signed off in April.